Subscribe To
Drug/biotech stocks' q4 earnings on feb 24: mrna, ebs & more
Let us take a look at five biotech/drug companies, namely, MRNA, EDIT, VIR, EBS and AERI, which are due to release their quarterly results on Feb 24....
February 23, 2022, 1:06 pm
Palo alto is leading the nasdaq higher, but 1 biotech is getting crushed wednesday
Investors are trying to take a longer-term view on the geopolitical situation....
February 23, 2022, 9:01 am
Palo alto is leading the nasdaq higher, but 1 biotech is getting crushed wednesday
Investors are trying to take a longer-term view on the geopolitical situation....
February 23, 2022, 9:01 am
Palo alto is leading the nasdaq higher, but 1 biotech is getting crushed wednesday
Investors are trying to take a longer-term view on the geopolitical situation....
February 23, 2022, 9:01 am
Biocept outlines how its cnside cerebrospinal fluid assay could improve treatment options for brain cancers
Biocept Inc (NASDAQ:BIOC) (Biocept Inc (NASDAQ:BIOC)) has highlighted how its CNSide cerebrospinal fluid (CSF) assay could improve the treatment optio...
February 23, 2022, 8:07 am
Biocept outlines how its cnside cerebrospinal fluid assay could improve treatment options for brain cancers
Biocept Inc (NASDAQ:BIOC) (Biocept Inc (NASDAQ:BIOC)) has highlighted how its CNSide cerebrospinal fluid (CSF) assay could improve the treatment optio...
February 23, 2022, 8:07 am
Biocept outlines how its cnside cerebrospinal fluid assay could improve treatment options for brain cancers
Biocept Inc (NASDAQ:BIOC) (Biocept Inc (NASDAQ:BIOC)) has highlighted how its CNSide cerebrospinal fluid (CSF) assay could improve the treatment optio...
February 23, 2022, 8:07 am
Verve therapeutics to present at the cowen 42nd annual healthcare conference
CAMBRIDGE, Mass., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Verve Therapeutics, a biotechnology company pioneering a new approach to the care of cardiovascula...
February 23, 2022, 6:30 am
Verve therapeutics to present at the cowen 42nd annual healthcare conference
CAMBRIDGE, Mass., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Verve Therapeutics, a biotechnology company pioneering a new approach to the care of cardiovascula...
February 23, 2022, 6:30 am
Verve therapeutics to present at the cowen 42nd annual healthcare conference
CAMBRIDGE, Mass., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Verve Therapeutics, a biotechnology company pioneering a new approach to the care of cardiovascula...
February 23, 2022, 6:30 am
Struggling biotech name to report earnings after the close
Halozyme Therapeutics Inc (NASDAQ:HALO) is gearing up for its fourth-quarter earnings report, due out after the close today, in which the company is e...
February 22, 2022, 2:34 pm
Struggling biotech name to report earnings after the close
Halozyme Therapeutics Inc (NASDAQ:HALO) is gearing up for its fourth-quarter earnings report, due out after the close today, in which the company is e...
February 22, 2022, 2:34 pm
Struggling biotech name to report earnings after the close
Halozyme Therapeutics Inc (NASDAQ:HALO) is gearing up for its fourth-quarter earnings report, due out after the close today, in which the company is e...
February 22, 2022, 2:34 pm
Drug/biotech stocks' q4 earnings on feb 23: bmrn, bhc & more
Let us take a look at five drug/biotech companies, namely, BMRN, CLVS, TBPH, BHC and GBT, which are due...
February 22, 2022, 1:05 pm
Drug/biotech stocks' q4 earnings on feb 23: bmrn, bhc & more
Let us take a look at five drug/biotech companies, namely, BMRN, CLVS, TBPH, BHC and GBT, which are due...
February 22, 2022, 1:05 pm
Drug/biotech stocks' q4 earnings on feb 23: bmrn, bhc & more
Let us take a look at five drug/biotech companies, namely, BMRN, CLVS, TBPH, BHC and GBT, which are due...
February 22, 2022, 1:05 pm
2 reasons to buy moderna, and 1 reason to sell
The story for this biotech is far from over -- but its path ahead may be more complicated....
February 22, 2022, 11:21 am
2 reasons to buy moderna, and 1 reason to sell
The story for this biotech is far from over -- but its path ahead may be more complicated....
February 22, 2022, 11:21 am
2 reasons to buy moderna, and 1 reason to sell
The story for this biotech is far from over -- but its path ahead may be more complicated....
February 22, 2022, 11:21 am
Pds biotechnology: versamune platform targeting hpv-associated cancers
PDS Biotechnology: Versamune Platform Targeting HPV-Associated Cancers...
February 21, 2022, 11:52 pm